This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory Vaccine distribution roadmap

West Africa Lassa Fever Vaccine Roadmap

Analysis based on 10 articles · First reported Feb 03, 2026 · Last updated Feb 06, 2026

Sentiment
40
Attention
2
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The launch of the Lassa Fever End-to-End Access Roadmap by the West African Health Organisation (WAHO) and Coalition for Epidemic Preparedness Innovations (CEPI) signals a coordinated effort to address a significant public health threat. This initiative could positively impact pharmaceutical companies involved in vaccine development and manufacturing, as well as healthcare systems in West Africa by reducing the burden of Lassa fever.

Pharmaceuticals Healthcare

The West African Health Organisation (WAHO), with support from the Coalition for Epidemic Preparedness Innovations (CEPI), launched the Lassa Fever End-to-End (E2E) Access Roadmap for West Africa in Abidjan, Ivory Coast. This roadmap aims to ensure fair distribution and access to Lassa fever vaccines, once approved, for high-risk populations across West Africa. The initiative covers all stages from research and development to deployment, emphasizing coordination among governments, manufacturers, funders, and partners to ensure affordability and accessibility. This launch coincides with progress in vaccine research, including a candidate Lassa fever vaccine developed by the University of Oxford entering Phase 1 trials. Nigeria, a high-burden country, is expected to host later trials, with its Nigeria===Nigeria Centre for Disease Control (NCDC) reporting recent cases and deaths. Experts stress that coordinated planning is essential for effective vaccine delivery.

90 West African Health Organisation launched Lassa Fever End-to-End Access Roadmap
60 Nigeria===Nigeria Centre for Disease Control reported Lassa fever cases and deaths
alliance
The West African Health Organisation (WAHO) is leading the Lassa Fever End-to-End (E2E) Access Roadmap for West Africa, ensuring fair distribution of Lassa fever vaccines. This initiative reflects regional ownership and aligns countries and partners for vaccine access.
Importance 90 Sentiment 50
ngo
The Coalition for Epidemic Preparedness Innovations (CEPI) supports the Lassa Fever End-to-End (E2E) Access Roadmap and has funded the development of a Lassa fever vaccine candidate by the University of Oxford. CEPI's involvement is crucial for vaccine development and equitable access.
Importance 80 Sentiment 50
cnt
Nigeria is identified as one of the highest-burden countries for Lassa fever, with planned later trials for the vaccine. The Nigeria===Nigeria Centre for Disease Control (NCDC) reported significant cases and deaths, underscoring the country's critical need for the vaccine.
Importance 70 Sentiment 0
per
Emma Wheatley, Executive Director at Coalition for Epidemic Preparedness Innovations (CEPI), emphasized the urgency of preparing for Lassa fever vaccine distribution. Her statements highlight the importance of early planning for vaccine access.
Importance 60 Sentiment 0
per
Virgil Lokossou, Director of Healthcare Services at West African Health Organisation (WAHO), stated that the roadmap reflects regional ownership and aligns partners for vaccine access. His comments emphasize the collaborative nature of the initiative.
Importance 50 Sentiment 0
govactor
The Nigeria===Nigeria Centre for Disease Control (NCDC) reported Lassa fever cases and deaths in Nigeria, highlighting the ongoing public health threat. The NCDC's data underscores the urgency of the vaccine distribution efforts.
Importance 40 Sentiment 0
cnt
Ivory Coast was the location for the unveiling of the Lassa Fever End-to-End (E2E) Access Roadmap for West Africa. Its role is primarily as a host for this significant regional event.
Importance 20 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.